Alan Colman

Alan Colman is currently an Independent Director at VolitionRX Ltd. and Volition America, Inc. since 2011, a Director at Gaibian Associates Pte Ltd., and an Associate at Harvard University.
Former positions include Research Director at PPL Therapeutics Plc from 1987 to 2002, Director at Singapore Volition Pte Ltd. from 2011 to 2015, Executive Director at The Singapore Stem Cell Consortium from 2006 to 2013, Executive Director at Astar Laboratory Pte Ltd. from 2007 to 2013, Professor-Biochemistry at the University of Birmingham from 1987 to 1992, Professor-Regenerative Medicine at King's College London from 2008 to 2009, Chief Executive & Scientific Officer at ES Cell International Pte Ltd. from 2002 to 2007, Professor at the University of Oxford, Professor at the University of Warwick, and Associate at Harvard Stem Cell Institute from 2014 to 2024.
Education includes undergraduate, graduate, and doctorate degrees from the University of Oxford conferred in 1971 and 1975, and a doctorate from the University of Cambridge conferred in 1974.